Press & Blog

The latest developments from Nerbio Medical Software Platforms Inc.

Nerbio's iTOF® Becomes the First FDA-Cleared App-Controlled Neuromuscular Blockade Monitor

San Jose, CA — Nerbio, a leader in intelligent patient monitoring solutions, proudly announces that its iTOF® device has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This milestone marks iTOF as the world's first wireless, app-controlled quantitative neuromuscular blockade (NMB) monitoring device to achieve FDA clearance.

Nerbio Launches U.S. Sales Operations from Memphis, Bringing Breakthrough Medical Device Innovation to the Mid-South

Memphis, TN — Nerbio, a fast-growing innovator in app-controlled patient monitoring technology, is proud to announce that it is establishing its U.S. sales operations in Memphis, Tennessee.

New Study Confirms High Adoption and Ease of Use of Nerbio’s iTOF® Monitoring System in Real-World Hospital Settings

San Jose, CA — Nerbio, a global innovator in mobile-based anesthesia and critical care monitoring solutions, today released results from a multi-center case study highlighting the successful clinical adoption of its flagship device, the iTOF®, in over 1,700 surgical cases across India. The study confirms that iTOF—an FDA-cleared, app-controlled neuromuscular monitoring device—is not only clinically effective but highly accepted by anesthesia professionals, overcoming one of the key barriers to widespread adoption of quantitative monitoring in surgery.

Press & Blog

The latest developments from Nerbio Medical Software Platforms Inc.

Nerbio's iTOF® Becomes the First FDA-Cleared App-Controlled Neuromuscular Blockade Monitor

Nerbio Launches U.S. Sales Operations from Memphis, Bringing Breakthrough Medical Device Innovation to the Mid-South

New Study Confirms High Adoption and Ease of Use of Nerbio’s iTOF® Monitoring System in Real-World Hospital Settings

Download the FREE iTOF App